Lumos Pharma Ratios and Metrics

Market cap in millions JPY. Fiscal year is April - March.

Millions JPY. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Aug '25 Aug 12, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Market Capitalization	730,591	563,602	974,391	-	-
Market Cap Growth	-26.70%	-42.16%	-	-	-
Enterprise Value	748,120	592,705	983,845	-	-
Last Close Price	3131.00	2423.00	4139.73	-	-
PE Ratio	24.93	15.65	43.55	-	-
Forward PE	17.43	14.40	32.06	-	-
PS Ratio	3.24	2.36	5.39	-	-
PB Ratio	3.67	2.87	5.20	-	-
P/TBV Ratio	8.43	6.79	13.66	-	-
P/FCF Ratio	38.59	43.37	-	-	-
P/OCF Ratio	18.58	14.65	331.20	-	-
PEG Ratio	1.20	4.42	4.28	-	-
EV/Sales Ratio	3.32	2.48	5.44	-	-
EV/EBITDA Ratio	13.29	9.28	23.52	-	-
EV/EBIT Ratio	17.33	11.57	31.85	-	-
EV/FCF Ratio	39.52	45.61	-	-	-
Debt / Equity Ratio	0.30	0.31	0.50	0.62	1.03
Debt / EBITDA Ratio	1.07	0.94	2.22	-	-
Debt / FCF Ratio	3.19	4.63	-	-	-
Asset Turnover	0.62	0.67	0.49	0.68	-
Inventory Turnover	1.53	1.61	1.37	2.44	-
Quick Ratio	1.03	1.06	1.42	1.56	1.57
Current Ratio	2.18	2.09	2.46	2.27	2.10
Return on Equity (ROE)	14.82%	18.77%	12.85%	28.75%	-
Return on Assets (ROA)	7.42%	8.93%	5.18%	9.64%	-
Return on Capital (ROIC)	9.78%	11.93%	7.14%	13.94%	-
Return on Capital Employed (ROCE)	16.50%	19.80%	10.70%	20.60%	27.40%
Earnings Yield	4.03%	6.39%	2.30%	-	-
FCF Yield	2.59%	2.31%	-0.88%	-	-
Dividend Yield	1.17%	1.53%	0.27%	-	-
Payout Ratio	29.37%	18.64%	-	-	-
Buyback Yield / Dilution	1.79%	1.15%	-0.02%	0.00%	-
Total Shareholder Return	2.97%	2.68%	0.24%	0.00%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.